Analysts Offer Insights on Healthcare Companies: Nexalin Technology, Inc. (NASDAQ: NXL) and Celldex (NASDAQ: CLDX)Nevertheless, we remain positive on the potential of NXL's innovative waveform technology as a solution for the treatment of Alzheimer's disease and other conditions; therefore, we maintain our Buy rating.